BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noronha AM, Liang Y, Hetzel JT, Hasturk H, Kantarci A, Stucchi A, Zhang Y, Nikolajczyk BS, Farraye FA, Ganley-Leal LM. Hyperactivated B cells in human inflammatory bowel disease. J Leukoc Biol. 2009;86:1007-1016. [PMID: 19589946 DOI: 10.1189/jlb.0309203] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hashash JG, Hartman DJ. Inflammatory cells implicated in neoplasia development in idiopathic inflammatory bowel disease. Cell Immunol 2019;343:103720. [PMID: 29221690 DOI: 10.1016/j.cellimm.2017.11.004] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Halwani R, Al-Kufaidy R, Vazquez-Tello A, Pureza MA, BaHammam AS, Al-Jahdali H, Alnassar SA, Hamid Q, Al-Muhsen S. IL-17 Enhances Chemotaxis of Primary Human B Cells during Asthma. PLoS One 2014;9:e114604. [PMID: 25494178 DOI: 10.1371/journal.pone.0114604] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
3 Yu W, Lin Z, Hegarty JP, John G, Chen X, Faber PW, Kelly AA, Wang Y, Poritz LS, Schreiber S, Koltun WA. Genes regulated by Nkx2-3 in siRNA-mediated knockdown B cells: implication of endothelin-1 in inflammatory bowel disease. Mol Genet Metab 2010;100:88-95. [PMID: 20188614 DOI: 10.1016/j.ymgme.2010.02.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
4 Do A, Reid RC, Lohman RJ, Sweet MJ, Fairlie DP, Iyer A. An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in Mice. J Pharmacol Exp Ther 2017;360:140-51. [PMID: 27827303 DOI: 10.1124/jpet.116.236711] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
5 Uzzan M, Colombel JF, Cerutti A, Treton X, Mehandru S. B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. Dig Dis Sci 2016;61:3407-24. [PMID: 27655102 DOI: 10.1007/s10620-016-4317-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
6 Onguru D, Liang Y, Elliot J, Mwinzi P, Ganley-Leal L. CD23b isoform expression in human schistosomiasis identifies a novel subset of activated B cells. Infect Immun 2011;79:3770-7. [PMID: 21708991 DOI: 10.1128/IAI.05094-11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Klapproth JM, Sasaki M. Bacterial induction of proinflammatory cytokines in inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:2173-2179. [PMID: 20848533 DOI: 10.1002/ibd.21332] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
8 Garrity-Park M, Loftus EV Jr, Sandborn WJ, Smyrk TC. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation. Inflamm Bowel Dis 2012;18:275-83. [PMID: 21425209 DOI: 10.1002/ibd.21681] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
9 Tanko RF, Soares AP, Müller TL, Garrett NJ, Samsunder N, Abdool Karim Q, Abdool Karim SS, Riou C, Burgers WA. Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African Women. J Immunol 2017;198:1220-8. [PMID: 28039305 DOI: 10.4049/jimmunol.1601560] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
10 Nikolajczyk BS. B cells as under-appreciated mediators of non-auto-immune inflammatory disease. Cytokine 2010;50:234-42. [PMID: 20382544 DOI: 10.1016/j.cyto.2010.02.022] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
11 Schnell A, Schwarz B, Wahlbuhl M, Allabauer I, Hess M, Weber S, Werner F, Schmidt H, Rechenauer T, Siebenlist G, Kaspar S, Ehrsam C, Rieger D, Rückel A, Metzler M, Christoph J, Woelfle J, Rascher W, Hoerning A. Distribution and Cytokine Profile of Peripheral B Cell Subsets Is Perturbed in Pediatric IBD and Partially Restored During a Successful IFX Therapy. Inflamm Bowel Dis 2021;27:224-35. [PMID: 32185399 DOI: 10.1093/ibd/izaa054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Xiong J, Zhou MF, Wang YD, Chen LP, Xu WF, Wang YD, Deng F, Liu SD. Protein Kinase D2 Protects against Acute Colitis Induced by Dextran Sulfate Sodium in Mice. Sci Rep 2016;6:34079. [PMID: 27659202 DOI: 10.1038/srep34079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
13 Lino AC, Dörner T, Bar-Or A, Fillatreau S. Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases. Immunol Rev 2016;269:130-44. [PMID: 26683150 DOI: 10.1111/imr.12374] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
14 Helbig S, Rekhtman S, Dostie K, Casler A, Schneider T, Hochberg NS, Ganley-Leal L. B cell responses in older adults with latent tuberculosis: Considerations for vaccine development. Glob Vaccines Immunol 2016;1:44-52. [PMID: 30271881 DOI: 10.15761/GVI.1000112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Fogel O, Richard-miceli C, Tost J. Epigenetic Changes in Chronic Inflammatory Diseases. Chromatin Remodelling and Immunity. Elsevier; 2017. pp. 139-89. [DOI: 10.1016/bs.apcsb.2016.09.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
16 Engel P, Gómez-Puerta JA, Ramos-Casals M, Lozano F, Bosch X. Therapeutic targeting of B cells for rheumatic autoimmune diseases. Pharmacol Rev 2011;63:127-56. [PMID: 21245206 DOI: 10.1124/pr.109.002006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 6.5] [Reference Citation Analysis]
17 Jagannathan M, McDonnell M, Liang Y, Hasturk H, Hetzel J, Rubin D, Kantarci A, Van Dyke TE, Ganley-Leal LM, Nikolajczyk BS. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia. 2010;53:1461-1471. [PMID: 20383694 DOI: 10.1007/s00125-010-1730-z] [Cited by in Crossref: 107] [Cited by in F6Publishing: 102] [Article Influence: 8.9] [Reference Citation Analysis]
18 Mizoguchi A, Bhan AK. Immunobiology of B Cells in Inflammatory Bowel Disease. In: Baumgart DC, editor. Crohn's Disease and Ulcerative Colitis. Cham: Springer International Publishing; 2017. pp. 111-7. [DOI: 10.1007/978-3-319-33703-6_9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
19 Liu O, Xu J, Ding G, Liu D, Fan Z, Zhang C, Chen W, Ding Y, Tang Z, Wang S. Periodontal ligament stem cells regulate B lymphocyte function via programmed cell death protein 1. Stem Cells. 2013;31:1371-1382. [PMID: 23553748 DOI: 10.1002/stem.1387] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
20 Jagannathan M, Hasturk H, Liang Y, Shin H, Hetzel JT, Kantarci A, Rubin D, McDonnell ME, Van Dyke TE, Ganley-Leal LM, Nikolajczyk BS. TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J Immunol 2009;183:7461-70. [PMID: 19917698 DOI: 10.4049/jimmunol.0901517] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 5.0] [Reference Citation Analysis]
21 McDonnell M, Liang Y, Noronha A, Coukos J, Kasper DL, Farraye FA, Ganley-Leal LM. Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease. Inflamm Bowel Dis 2011;17:298-307. [PMID: 20806343 DOI: 10.1002/ibd.21424] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
22 Ganley-Leal LM, Liang Y, Jagannathan-Bogdan M, Farraye FA, Nikolajczyk BS. Differential regulation of TLR4 expression in human B cells and monocytes. Mol Immunol 2010;48:82-8. [PMID: 20956019 DOI: 10.1016/j.molimm.2010.09.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
23 Leppkes M, Neurath MF, Herrmann M, Becker C. Immune deficiency vs. immune excess in inflammatory bowel diseases-STAT3 as a rheo-STAT of intestinal homeostasis. J Leukoc Biol 2016;99:57-66. [PMID: 26232455 DOI: 10.1189/jlb.5MR0515-221R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
24 Kosoy R, Kim-Schulze S, Rahman A, Friedman JR, Huang R, Peters LA, Amir EA, Perrigoue J, Stojmirovic A, Song WM, Ke H, Ungaro R, Mehandru S, Cho J, Dubinsky M, Curran M, Brodmerkel C, Schadt EE, Sands BE, Colombel JF, Kasarskis A, Argmann CA, Suárez-Fariñas M. Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination Therapy. Cell Mol Gastroenterol Hepatol 2021;12:599-632. [PMID: 33813036 DOI: 10.1016/j.jcmgh.2021.03.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Li Z, Vermeire S, Bullens D, Ferrante M, Van Steen K, Noman M, Bossuyt X, Rutgeerts P, Ceuppens JL, Van Assche G. Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2015;21:2787-96. [PMID: 26383913 DOI: 10.1097/MIB.0000000000000554] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
26 Penney J, Lu Y, Pan B, Feng Y, Walk C, Li J. Pure yeast beta-glucan and two types of yeast cell wall extracts enhance cell migration in porcine intestine model. Journal of Functional Foods 2019;59:129-37. [DOI: 10.1016/j.jff.2019.05.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Bao Y, Cao X. The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review. J Autoimmun 2014;55:10-23. [PMID: 24794622 DOI: 10.1016/j.jaut.2014.04.001] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 10.6] [Reference Citation Analysis]
28 Yadav V, Varum F, Bravo R, Furrer E, Bojic D, Basit AW. Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets. Transl Res 2016;176:38-68. [PMID: 27220087 DOI: 10.1016/j.trsl.2016.04.009] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 14.2] [Reference Citation Analysis]
29 Shivshankar P, Li YD, Mueller-Ortiz SL, Wetsel RA. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells. FASEB J 2020;34:7540-60. [PMID: 32301538 DOI: 10.1096/fj.201902397R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
30 Strissel KJ, Denis GV, Nikolajczyk BS. Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease. Curr Opin Endocrinol Diabetes Obes 2014;21:330-8. [PMID: 25106001 DOI: 10.1097/MED.0000000000000085] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 3.9] [Reference Citation Analysis]
31 Elvington M, Schepp-Berglind J, Tomlinson S. Regulation of the alternative pathway of complement modulates injury and immunity in a chronic model of dextran sulphate sodium-induced colitis. Clin Exp Immunol 2015;179:500-8. [PMID: 25293413 DOI: 10.1111/cei.12464] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
32 Li Y, de Haar C, Peppelenbosch MP, van der Woude CJ. SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer. Cytokine Growth Factor Rev 2012;23:127-38. [PMID: 22591635 DOI: 10.1016/j.cytogfr.2012.04.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
33 Xu J, Xu H, Yang M, Liang Y, Peng Q, Zhang Y, Tian C, Wang L, Yao J, Nie Y, Li D. New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease. Front Pharmacol 2022;13:813659. [DOI: 10.3389/fphar.2022.813659] [Reference Citation Analysis]
34 Neeland MR, Martino DJ, Dang TD, Koplin JJ, Peters RL, Grishin A, Dharmage SC, Tang ML, Sampson HA, Saffery R, Allen KJ. B‐cell phenotype and function in infants with egg allergy. Allergy 2019;74:1022-5. [DOI: 10.1111/all.13707] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
35 Lakhan SE, Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J Neuroinflammation. 2010;7:37. [PMID: 20615234 DOI: 10.1186/1742-2094-7-37] [Cited by in Crossref: 111] [Cited by in F6Publishing: 109] [Article Influence: 9.3] [Reference Citation Analysis]
36 Frasca D, Andrisani G, Diaz A, Felice C, Guidi L, Blomberg BB. AID in aging and autoimmune diseases. Autoimmunity 2013;46:168-75. [PMID: 23190037 DOI: 10.3109/08916934.2012.750300] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
37 Zhang P, Liu X, Guo A, Xiong J, Fu Y, Zou K. B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease. Dig Dis Sci 2016;61:2608-18. [DOI: 10.1007/s10620-016-4136-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
38 Lv Q, Xing Y, Liu Y, Chen Q, Xu J, Hu L, Zhang Y. Didymin switches M1-like toward M2-like macrophage to ameliorate ulcerative colitis via fatty acid oxidation. Pharmacol Res 2021;169:105613. [PMID: 33915297 DOI: 10.1016/j.phrs.2021.105613] [Reference Citation Analysis]
39 Berkowitz D, Peri R, Lavy A, Kessel A. Increased Toll-like receptor 9 expression by B cells from inflammatory bowel disease patients. Hum Immunol. 2013;74:1519-1523. [PMID: 24007656 DOI: 10.1016/j.humimm.2013.08.285] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
40 Miyazaki H, Takabe K, Yeudall WA. Chemokines, chemokine receptors and the gastrointestinal system. World J Gastroenterol 2013; 19(19): 2847-2863 [PMID: 23704819 DOI: 10.3748/wjg.v19.i19.2847] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
41 Palma P, Rinaldi S, Cotugno N, Santilli V, Pahwa S, Rossi P, Cagigi A. Premature B-cell senescence as a consequence of chronic immune activation. Hum Vaccin Immunother 2014;10:2083-8. [PMID: 25424820 DOI: 10.4161/hv.28698] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
42 Griffith QK, Liang Y, Onguru DO, Mwinzi PN, Ganley-Leal LM. CD23-bound IgE augments and dominates recall responses through human naive B cells. J Immunol 2011;186:1060-7. [PMID: 21160045 DOI: 10.4049/jimmunol.1002709] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
43 Preisker S, Brethack AK, Bokemeyer A, Bettenworth D, Sina C, Derer S. Crohn's Disease Patients in Remission Display an Enhanced Intestinal IgM⁺ B Cell Count in Concert with a Strong Activation of the Intestinal Complement System. Cells 2019;8:E78. [PMID: 30669641 DOI: 10.3390/cells8010078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
44 Farb MG, Ganley-Leal L, Mott M, Liang Y, Ercan B, Widlansky ME, Bigornia SJ, Fiscale AJ, Apovian CM, Carmine B, Hess DT, Vita JA, Gokce N. Arteriolar function in visceral adipose tissue is impaired in human obesity. Arterioscler Thromb Vasc Biol 2012;32:467-73. [PMID: 22095978 DOI: 10.1161/ATVBAHA.111.235846] [Cited by in Crossref: 64] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
45 Onguru D, Liang Y, Griffith Q, Nikolajczyk B, Mwinzi P, Ganley-Leal L. Human schistosomiasis is associated with endotoxemia and Toll-like receptor 2- and 4-bearing B cells. Am J Trop Med Hyg 2011;84:321-4. [PMID: 21292908 DOI: 10.4269/ajtmh.2011.10-0397] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
46 Obeid S, Wankell M, Charrez B, Sternberg J, Kreuter R, Esmaili S, Ramezani-Moghadam M, Devine C, Read S, Bhathal P, Lopata A, Ahlensteil G, Qiao L, George J, Hebbard L. Adiponectin confers protection from acute colitis and restricts a B cell immune response. J Biol Chem 2017;292:6569-82. [PMID: 28258220 DOI: 10.1074/jbc.M115.712646] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
47 Lin Z, Hegarty JP, Yu W, Cappel JA, Chen X, Faber PW, Wang Y, Poritz LS, Fan JB, Koltun WA. Identification of disease-associated DNA methylation in B cells from Crohn’s disease and ulcerative colitis patients. Dig Dis Sci. 2012;57:3145-3153. [PMID: 22821069 DOI: 10.1007/s10620-012-2288-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
48 Pizarro TT, Pastorelli L, Bamias G, Garg RR, Reuter BK, Mercado JR, Chieppa M, Arseneau KO, Ley K, Cominelli F. SAMP1/YitFc mouse strain: a spontaneous model of Crohn’s disease-like ileitis. Inflamm Bowel Dis. 2011;17:2566-2584. [PMID: 21557393 DOI: 10.1002/ibd.21638] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 9.0] [Reference Citation Analysis]
49 Deutschmann C, Roggenbuck D, Schierack P. The loss of tolerance to CHI3L1 – A putative role in inflammatory bowel disease? Clinical Immunology 2019;199:12-7. [DOI: 10.1016/j.clim.2018.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
50 Lorenzo MM, Devlin J, Saini C, Cho KS, Paschalis EI, Chen DF, Nascimento E Silva R, Chen SH, Margeta MA, Ondeck C, Solá-Del Valle D, Chodosh J, Ciolino JB, Pineda R, Pasquale LR, Shen LQ. The Prevalence of Autoimmune Diseases in Patients with Primary Open-Angle Glaucoma Undergoing Ophthalmic Surgeries. Ophthalmol Glaucoma 2021:S2589-4196(21)00186-1. [PMID: 34416426 DOI: 10.1016/j.ogla.2021.08.003] [Reference Citation Analysis]
51 Duarte PM, Szeremeske Miranda T, Lima JA, Dias Gonçalves TE, Santos VR, Bastos MF, Ribeiro FV. Expression of Immune-Inflammatory Markers in Sites of Chronic Periodontitis in Patients With Type 2 Diabetes. Journal of Periodontology 2012;83:426-34. [DOI: 10.1902/jop.2011.110324] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
52 Beatty JK, Akierman SV, Motta JP, Muise S, Workentine ML, Harrison JJ, Bhargava A, Beck PL, Rioux KP, McKnight GW, Wallace JL, Buret AG. Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms. Int J Parasitol 2017;47:311-26. [PMID: 28237889 DOI: 10.1016/j.ijpara.2016.11.010] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 14.8] [Reference Citation Analysis]
53 Kang Z, Zhonga Y, Wu T, Huang J, Zhao H, Liu D. Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease. Pharmacol Rep 2021;73:700-11. [PMID: 33462754 DOI: 10.1007/s43440-020-00213-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Rehman MQ, Beal D, Liang Y, Noronha A, Winter H, Farraye FA, Ganley-Leal L. B cells secrete eotaxin-1 in human inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:922-933. [PMID: 23511032 DOI: 10.1097/mib.0b013e3182802950] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
55 Zhang S, Langer R, Traverso G. Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease. Nano Today 2017;16:82-96. [PMID: 31186671 DOI: 10.1016/j.nantod.2017.08.006] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 11.2] [Reference Citation Analysis]
56 Allain T, Amat CB, Motta JP, Manko A, Buret AG. Interactions of Giardia sp. with the intestinal barrier: Epithelium, mucus, and microbiota. Tissue Barriers 2017;5:e1274354. [PMID: 28452685 DOI: 10.1080/21688370.2016.1274354] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]